These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9711595)

  • 21. The beta-cell sulfonylurea receptor.
    Ashcroft SJ; Niki I; Kenna S; Weng L; Skeer J; Coles B; Ashcroft FM
    Adv Exp Med Biol; 1993; 334():47-61. PubMed ID: 8249695
    [No Abstract]   [Full Text] [Related]  

  • 22. The binding properties of the solubilized sulfonylurea receptor from a pancreatic B-cell line are modulated by the Mg(++)-complex of ATP.
    Schwanstecher M; Behrends S; Brandt C; Panten U
    J Pharmacol Exp Ther; 1992 Aug; 262(2):495-502. PubMed ID: 1501109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of functional diversity of ATP-sensitive K+ channels.
    Seino S; Inagaki N; Namba N; Wang CH; Kotake K; Nagashima K; Miki T; Aguilar-Bryan L; Bryan J; Gonoi T
    Jpn J Physiol; 1997; 47 Suppl 1():S3-4. PubMed ID: 9266305
    [No Abstract]   [Full Text] [Related]  

  • 24. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.
    Inagaki N; Gonoi T; Clement JP; Namba N; Inazawa J; Gonzalez G; Aguilar-Bryan L; Seino S; Bryan J
    Science; 1995 Nov; 270(5239):1166-70. PubMed ID: 7502040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: ATP-sensitive potassium channel and insulin secretion].
    Seino S
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1155-7. PubMed ID: 12056011
    [No Abstract]   [Full Text] [Related]  

  • 26. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
    Russ U; Hambrock A; Artunc F; Löffler-Walz C; Horio Y; Kurachi Y; Quast U
    Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
    Gros L; Virsolvy A; Salazar G; Bataille D; Blache P
    Biochem Biophys Res Commun; 1999 Apr; 257(3):766-70. PubMed ID: 10208857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ATP-sensitive K+ channel].
    Nagashima K
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():548-52. PubMed ID: 12238096
    [No Abstract]   [Full Text] [Related]  

  • 29. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
    Ueda K; Komine J; Matsuo M; Seino S; Amachi T
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The high-affinity sulfonylurea receptor: distribution, glycosylation, purification, and immunoprecipitation of two forms from endocrine and neuroendocrine cell lines.
    Nelson DA; Bryan J; Wechsler S; Clement JP; Aguilar-Bryan L
    Biochemistry; 1996 Nov; 35(47):14793-9. PubMed ID: 8942641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
    Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
    EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the sulfonylurea receptor on beta cell membranes.
    Gaines KL; Hamilton S; Boyd AE
    J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the molecular assembly of beta-cell K(ATP) channels.
    Mikhailov MV; Mikhailova EA; Ashcroft SJ
    FEBS Lett; 2000 Sep; 482(1-2):59-64. PubMed ID: 11018523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exciting times for PIP2.
    Ashcroft FM
    Science; 1998 Nov; 282(5391):1059-60. PubMed ID: 9841452
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular biology of the KATP channel. Where's the clone?
    Nichols CG
    Cardiovasc Res; 1994 Jun; 28(6):727-8. PubMed ID: 7923270
    [No Abstract]   [Full Text] [Related]  

  • 37. [Structure of ATP-dependent potassium channels: SUR/Kir6 molecular complex].
    Quast U
    Journ Annu Diabetol Hotel Dieu; 2000; ():1-12. PubMed ID: 10932864
    [No Abstract]   [Full Text] [Related]  

  • 38. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
    Stephan D; Winkler M; Kühner P; Russ U; Quast U
    Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
    Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
    Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.